$HIMS stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal
Novo Nordisk confirmed it has withdrawn the legal case it had filed against Hims over alleged patent infringement linked to compounded versions of semaglutide.
$HIMS stock jumps 50% as Novo Nordisk ends lawsuit, strikes deal
Novo Nordisk confirmed it has withdrawn the legal case it had filed against Hims over alleged patent infringement linked to compounded versions of semaglutide.